We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

585 hedge funds and large institutions have $2.19B invested in iShares US Medical Devices ETF in 2023 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 168 increasing their positions, 233 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 38

5% more funds holding

Funds holding: 557585 (+28)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

4% less capital invested

Capital invested by funds: $2.28B → $2.19B (-$81.5M)

2.34% less ownership

Funds ownership: 38.08%35.74% (-2.3%)

28% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 233

32% less call options, than puts

Call options by funds: $12.4M | Put options by funds: $18.1M

Holders
585
Holders Change
+28
Holders Change %
+5.03%
% of All Funds
9.19%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.24%
New
68
Increased
168
Reduced
233
Closed
38
Calls
$12.4M
Puts
$18.1M
Net Calls
-$5.71M
Net Calls Change
-$14M
Name Holding Trade Value Shares
Change
Change in
Stake
BCA
226
Bay Colony Advisors
Massachusetts
$992K +$90.1K +1,636 +10%
MIFH
227
Migdal Insurance & Financial Holdings
Israel
$991K +$512K +9,289 +112%
Citadel Advisors
228
Citadel Advisors
Florida
$989K -$2.18M -39,557 -69%
EL
229
EQ LLC
Washington
$988K -$29.4K -534 -3%
PFP
230
Paragon Financial Partners
California
$985K -$27.3K -495 -3%
MA
231
Mezzasalma Advisors
New Jersey
$983K -$11.7K -212 -1%
BNP Paribas Financial Markets
232
BNP Paribas Financial Markets
France
$975K -$1.43M -25,960 -60%
MWM
233
Mascoma Wealth Management
New Hampshire
$973K -$296K -5,379 -23%
Vontobel Holding
234
Vontobel Holding
Switzerland
$962K
CIC
235
Carnegie Investment Counsel
Ohio
$962K -$2.7K -49 -0.3%
UWM
236
USAdvisors Wealth Management
Minnesota
$948K -$351K -6,375 -27%
EDRH
237
Edmond de Rothschild Holding
Switzerland
$933K +$13.9K +252 +2%
P
238
&Partners
Tennessee
$927K -$51.5K -935 -5%
KA
239
Kovack Advisors
Florida
$916K -$92.6K -1,682 -9%
Millennium Management
240
Millennium Management
New York
$914K +$892K +16,197 New
VWM
241
Venturi Wealth Management
Texas
$913K +$401K +7,278 +82%
LHWM
242
Lake Hills Wealth Management
Texas
$886K +$865K +15,701 New
CAG
243
Csenge Advisory Group
Florida
$880K -$38.8K -704 -4%
TSWM
244
Triangle Securities Wealth Management
North Carolina
$872K -$12.1K -220 -1%
VFG
245
V2 Financial group
Illinois
$869K
CB
246
Commerce Bank
Missouri
$868K
TJHA
247
Thomas J. Herzfeld Advisors
Florida
$849K -$165K -3,000 -17%
USCWA
248
U.S. Capital Wealth Advisors
Texas
$841K -$20.9K -380 -2%
STA
249
Summit Trail Advisors
New York
$839K
CIAS
250
Capital Investment Advisory Services
North Carolina
$837K -$1.54K -28 -0.2%

IHI Hedge Fund Activity: Q2 2023 in Review

585 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2023, worth a combined $2.19B — down 3.6% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new IHI positions and 38 closed out — a net gain of 30 holders — while 168 added to existing stakes and 233 trimmed.

The largest buyer was LPL Financial, adding an estimated $13.5M. The largest seller was Menora Mivtachim Holdings, exiting entirely with an estimated $107M sold.

  • 585 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2023, up from 557 in Q1 2023.
  • Funds reported $2.19B of iShares US Medical Devices ETF stock for Q2 2023, down 3.6% quarter-over-quarter.
  • 68 funds opened new iShares US Medical Devices ETF positions in Q2 2023 and 38 closed out, a net change of +30 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2023 was LPL Financial, an estimated $13.5M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2023 was Menora Mivtachim Holdings, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.